What Is a Peptide? A Plain-English Introduction

Your body is already running on peptides. Insulin is one. So is oxytocin. So is the growth hormone your pituitary gland releases during deep sleep, and the ghrelin that tells your brain you're hungry. The word gets used a lot in fitness and research circles, often without much explanation, so let's start with what's actually happening at a molecular level.

The Basic Definition

A peptide is a short chain of amino acids linked together by peptide bonds. Amino acids are the building blocks of all proteins, and when you string them together you get either a peptide or a protein depending on the length. The rough dividing line is 50 amino acids — below that it's a peptide, above that it's a protein. Most of the research peptides people use contain between 2 and 40 amino acids.

Size matters here. Smaller chains behave differently in the body. They're absorbed more readily, they break down faster, and they can be designed to target very specific biological processes without the broad systemic effects you'd get from, say, a full protein or a steroid hormone.

What Peptides Actually Do

Peptides are signalling molecules. They don't do the heavy lifting themselves — they tell other parts of your body what to do. Think of them as instructions rather than actions.

One peptide might signal your pituitary gland to release growth hormone. Another triggers collagen synthesis in connective tissue. Another reduces inflammatory signalling in the gut wall. The specificity is what makes peptide research interesting — it's possible to design compounds that bind to particular receptors and produce a fairly targeted effect, which is a different proposition from flooding the body with a non-specific hormonal signal.

Natural vs Synthetic

Most of the peptides studied for recovery and performance are either identical to peptides your body already produces, or are modified versions of naturally occurring sequences. BPC-157 is derived from a protein found in human gastric juice. Ipamorelin mimics the structure of ghrelin. Semaglutide is based on GLP-1, a hormone your gut releases after eating.

Synthetic versions are typically engineered to be more stable, longer-acting, or more receptor-specific than the natural version. Your body produces these signals constantly, but often in quantities or durations that researchers think could be adjusted for specific therapeutic outcomes.

How They're Administered

Most research peptides are given subcutaneously — injected into the layer of fat just beneath the skin, typically in the abdomen. This bypasses the digestive system, where the peptide would otherwise be broken down into its component amino acids before it could reach the bloodstream. A small needle, a small volume, and the peptide enters the system intact.

Some compounds are being developed as nasal sprays or oral formulations, but subcutaneous injection remains the standard for most peptides currently being studied. BPC-157 is a notable exception — it has shown oral bioavailability in animal studies, which makes it genuinely unusual in this category.

Why the Research Has Accelerated

Peptide synthesis has become significantly cheaper over the past two decades. What once required considerable laboratory resources can now be produced economically, which has expanded both legitimate pharmaceutical research and the grey-market availability of compounds that haven't completed clinical trials.

At the same time, our understanding of receptor pharmacology has improved enough that researchers can now design peptides with a reasonable expectation of how they'll behave. That's led to some genuinely striking results in animal studies across a range of applications — injury healing, metabolic function, cognitive performance, sexual health — which in turn drives the human experimentation that precedes formal trials.

GLP-1 agonists like semaglutide completed that journey and are now among the most prescribed drugs in the world. Other compounds remain firmly in research territory, used by people who want access to potential benefits ahead of the clinical process — which, at its slowest, can take decades.

The Honest Picture

Peptide research sits in an unusual position. For many compounds, the animal data is compelling and extensive. The human evidence is largely anecdotal — detailed and consistent enough to be meaningful, but not the same as a randomised controlled trial. Anyone engaging with these substances is operating in that gap.

Understanding what peptides are and how they work doesn't resolve that uncertainty, but it's the necessary starting point for thinking clearly about the rest of it.